MEI Pharma Inc (MEIP)
3.01
-0.02
(-0.66%)
USD |
NASDAQ |
Nov 14, 16:00
3.00
-0.01
(-0.33%)
After-Hours: 20:00
MEI Pharma Cash and Short Term Investments (Quarterly): 38.34M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 38.34M |
| March 31, 2024 | 56.55M |
| December 31, 2023 | 59.48M |
| September 30, 2023 | 82.20M |
| June 30, 2023 | 100.69M |
| March 31, 2023 | 112.04M |
| December 31, 2022 | 124.17M |
| September 30, 2022 | 138.37M |
| June 30, 2022 | 153.25M |
| March 31, 2022 | 169.04M |
| December 31, 2021 | 185.75M |
| September 30, 2021 | 145.50M |
| June 30, 2021 | 153.43M |
| March 31, 2021 | 164.62M |
| December 31, 2020 | 180.14M |
| September 30, 2020 | 176.14M |
| June 30, 2020 | 182.63M |
| March 31, 2020 | 92.80M |
| December 31, 2019 | 103.88M |
| September 30, 2019 | 65.92M |
| June 30, 2019 | 74.49M |
| March 31, 2019 | 82.29M |
| December 31, 2018 | 93.42M |
| September 30, 2018 | 90.76M |
| June 30, 2018 | 102.74M |
| Date | Value |
|---|---|
| March 31, 2018 | 36.20M |
| December 31, 2017 | 42.44M |
| September 30, 2017 | 47.02M |
| June 30, 2017 | 53.56M |
| March 31, 2017 | 56.76M |
| December 31, 2016 | 55.15M |
| September 30, 2016 | 58.90M |
| June 30, 2016 | 45.92M |
| March 31, 2016 | 49.40M |
| December 31, 2015 | 53.79M |
| September 30, 2015 | 58.02M |
| June 30, 2015 | 63.78M |
| March 31, 2015 | 70.52M |
| December 31, 2014 | 78.71M |
| September 30, 2014 | 42.06M |
| June 30, 2014 | 48.79M |
| March 31, 2014 | 54.68M |
| December 31, 2013 | 59.76M |
| September 30, 2013 | 31.50M |
| June 30, 2013 | 35.57M |
| March 31, 2013 | 24.17M |
| December 31, 2012 | 26.88M |
| September 30, 2012 | 3.713M |
| June 30, 2012 | 6.202M |
| March 31, 2012 | 2.722M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
38.34M
Minimum
Jun 2024
185.75M
Maximum
Dec 2021
127.32M
Average
138.37M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Avid Bioservices Inc | 33.38M |
| Evoke Pharma Inc | 11.34M |
| Revance Therapeutics Inc | 184.08M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |